State-backed Biovac clinches deal with ImmunityBio to make Covid-19 vaccines
If the phase 1 trial demonstrates the vaccine elicits a response, larger phase 2 and 3 trials will be conducted during the year
State-backed vaccine manufacturer Biovac has entered into a partnership with California-based ImmunityBio for local production of its candidate Covid-19 vaccine, it announced on Thursday.
The agreement is strategically important because it paves the way for Biovac to develop the expertise to manufacture active pharmaceutical ingredients (APIs), said CEO Morena Makhoana...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.